این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
شنبه 17 آبان 1404
Avicenna Journal of Phytomedicine
، جلد ۱۲، شماره ۶، صفحات ۵۵۹-۵۶۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
An open-label study on the short-term effects of a novel EFSA-compliant nutraceutical combination in mild-to-moderate hypercholesterolemia
چکیده انگلیسی مقاله
Objective: Recently, the European Food Safety Authority (EFSA) has recommended to limit the use of total monacolins in red yeast rice (RYR) products to a dose < 3 mg/day. However, data concerning the lipid lowering efficacy of the reduced dosage remain limited. A monacolin dose reduced due to safety issues may be expected to be less effective as a lipid lowering strategy and, for this reason, nutraceutical combinations with other active compounds may offer a viable solution as they can act synergistically through different mechanisms.Materials and Methods: This 8-week open-label study was designed to investigate the safety and efficacy of a novel ESFA-compliant lipid lowering nutraceutical combination (Colestarmony Plus®; containing total monacolins from RYR at a dose of 2.9 mg/day, a highly bioavailable berberine formulation, and pomegranate extract) in subjects (n=40) with mild-to-moderate hypercholesterolemia and no history of cardiovascular disease.Results: After 8 weeks of supplementation, Colestarmony Plus® significantly reduced total cholesterol (−10.4%, p< 0.05), low-density lipoprotein cholesterol (−14.8%, p< 0.05), oxidized low-density lipoprotein cholesterol (−12.0%, p< 0.05), and high-sensitivity C-reactive protein (−14.0%, p< 0.05) compared with baseline values. A subgroup of 22 patients underwent measurements of flow-mediated dilation, with values increasing by 18.0% at 8 weeks with respect to baseline (p< 0.05). The supplement was generally well-tolerated.Conclusion: Our short-term results indicate that the tested ESFA-compliant nutraceutical is effective in a primary prevention setting, even by providing only < 3 mg/day of monacolins.
کلیدواژههای انگلیسی مقاله
Monacolins, Berberine, Pomegranate, Nutraceutical, Hypercholesterolemia, Primary prevention
نویسندگان مقاله
| Piercarlo Minoretti
Studio Minoretti, Oggiono (LC), Italy
| Marco Biagi
Department of Environment, Earth and Physical Sciences, University of Siena, Siena, Italy
| Enzo Emanuele
2E Science, Robbio (PV), Italy
نشانی اینترنتی
https://ajp.mums.ac.ir/article_20662.html
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Short communication
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات